<DOC>
	<DOCNO>NCT01548729</DOCNO>
	<brief_summary>Patients end-stage cystic fibrosis ( CF ) severe CF-related diabetes ( CFRD ) may benefit combined lung-pancreatic islet transplantation . A recent case series show combined bilateral lung pancreatic islet transplantation viable therapeutic option patient end-stage CF CFRD . The use different organ single donor may lead reduce immunogenicity . As prevalence CFRD increase dramatically improve life expectancy patient CF , islet transplantation consider end-stage CF . By restore metabolic control , investigator hypothesize islet transplantation may improve management CF patient undergo lung transplant decrease complication rate early postoperative period .</brief_summary>
	<brief_title>Metabolic Efficiency Combined Pancreatic Islet Lung Transplant Treatment End-Stage Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Inclusion criterion : Age &gt; 18 Patient cystic fibrosis Patient able respect protocol procedure Patient endstage respiratory insufficiency indicate lung transplant Patient insulin therapy Clinical history cystic fibrosis relate diabetes residual insulin secretion ( Cpeptide &lt; 0,5 ng/mL ) response IV glucagon stimulation : [ peak stimulate Cpeptide ( T6min ) /basal plasma Cpeptide ( T0 ) ] &lt; 2 The absence insulin secretion verify 2 time inclusion Cystic fibrosis relate diabetes duration &gt; 3 year Patient whose glycaemic control obtain insulin therapy satisfactory could significantly alter quality life ( HbA1c &gt; 7 % and/or MAGE index &gt; 1,25 ) . This situation assess diabetologist . Social Security membership benefit Social Welfare Patient receive result medical evaluation require Exclusion criterion : Cystic fibrosis relate diabetes duration &lt; 3 year Patient contraindication undergo lung transplant Patient oral antidiabetic drug Criteria specifically related islet intraportal injection procedure : haemostasis problem , abnormalities complete blood count , document liver pathology ( alkaline phosphatase , gamma GT , transaminases level three time normal value ) ; pancreatitis history , gallbladder stone could potentially migrate ; HLA hyperimmunisation ( PRA &gt; 20 % ) . Portal hypertension identify oesophageal varice and/or hypersplenism ( platelet &lt; 120 000 /mm3 ) ChildPugh score &gt; 6 . Exclusion criterion nonspecifically related islet infusion : evolutive vascular disease , evolutive cardiopathy ( especially myocardial infarction le 6 month ago , cerebrovascular stroke less 6 month ago , evolutive arteritis trophic disorder ) ; systemic infection include hepatitis B C HIV ; leuconeutropenia ( &lt; 1 500/μL ) ; thrombocytopenia ( &lt; 100 000/μL ) , nonstabilized neoplastic pathology ; antecedent breast cancer melanoma ; pregnancy project pregnancy within next 24 month current breastfeeding ; poor therapeutic compliance Alcoholic intoxication drug addiction Use medical treatment investigation within one month inclusion Patient restrict freedom unable give consent All medical situation assess investigator could interfere good management project</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Diabetes Related Cystic Fibrosis</keyword>
	<keyword>Lung transplantation</keyword>
	<keyword>Pancreatic islet</keyword>
</DOC>